Listed

Arbutus Biopharma Corp: Form 20-F for the period ended Dec 31, 2012

Filed with the SEC on Mar 27, 2013 and accepted by EDGAR at Mar 27, 2013, 16:59 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Diluted shares (weighted)12 months2012-01-01 to 2012-12-3114,320,814 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Shares outstandingAt period end2012-12-3114,305,356 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001193125-13-129590. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.